| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11745-002-0978-Z |
| P698 | PubMed publication ID | 12458627 |
| P2093 | author name string | Lester E Wold | |
| Patricia C Schmid | |||
| Harald H O Schmid | |||
| Randy J Krebsbach | |||
| Evgueni V Berdyshev | |||
| P2860 | cites work | Imaging biochemistry: applications to breast cancer | Q24801126 |
| A simple method for the isolation and purification of total lipides from animal tissues | Q25939009 | ||
| Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells | Q28345246 | ||
| Cannabinoid-receptor-independent cell signalling by N-acylethanolamines | Q28363293 | ||
| Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation | Q28372120 | ||
| Isolation and structure of a brain constituent that binds to the cannabinoid receptor | Q29547476 | ||
| Phosphorus assay in column chromatography | Q29614973 | ||
| Gas chromatography-mass spectrometry analysis of endogenous cannabinoids in healthy and tumoral human brain and human cells in culture | Q32035079 | ||
| Lipid characteristics in metastatic cells | Q33764281 | ||
| Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. | Q33885039 | ||
| The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. | Q34066911 | ||
| Pathways and mechanisms of N-acylethanolamine biosynthesis: can anandamide be generated selectively? | Q34098970 | ||
| The fatty acid amide hydrolase (FAAH). | Q34098981 | ||
| N-Acylethanolamines and precursor phospholipids - relation to cell injury | Q34098995 | ||
| Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders | Q34099017 | ||
| Properties of rat liver N-acylethanolamine amidohydrolase | Q34200418 | ||
| 'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance. | Q34472174 | ||
| Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation | Q36111506 | ||
| N-acylated glycerophospholipids and their derivatives | Q37793330 | ||
| Stress-induced generation of N-acylethanolamines in mouse epidermal JB6 P+ cells | Q40891930 | ||
| Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells | Q40910820 | ||
| Malignant breast tumor phospholipid profiles using (31)P magnetic resonance | Q43862592 | ||
| Changes in lipid composition of neuroblastoma C1300 N18 cell during differentiation | Q69213813 | ||
| Characterization of malignant colon tumors with 31P nuclear magnetic resonance phospholipid and phosphatic metabolite profiles | Q71066996 | ||
| Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide | Q71743278 | ||
| Biosynthesis and turnover of anandamide and other N-acylethanolamines in peritoneal macrophages | Q73047443 | ||
| Anandamide and other N-acylethanolamines in mouse peritoneal macrophages | Q73636073 | ||
| P433 | issue | 9 | |
| P921 | main subject | anandamide | Q410228 |
| cannabinoids | Q422936 | ||
| P304 | page(s) | 907-912 | |
| P577 | publication date | 2002-09-01 | |
| P1433 | published in | Lipids | Q15756668 |
| P1476 | title | Anandamide and other N-acylethanolamines in human tumors | |
| P478 | volume | 37 |
| Q48771878 | Alteration of endocannabinoid system in human gliomas |
| Q40182562 | Anandamide protects from low serum-induced apoptosis via its degradation to ethanolamine |
| Q38806270 | Antitumorigenic targets of cannabinoids - current status and implications |
| Q27694715 | Cannabinoids, endocannabinoids, and cancer |
| Q35035836 | Cell signaling by endocannabinoids and their congeners: questions of selectivity and other challenges |
| Q37568679 | Changes in the endocannabinoid system may give insight into new and effective treatments for cancer |
| Q36416357 | Compartmentalization of endocannabinoids into lipid rafts in a dorsal root ganglion cell line |
| Q41068663 | Effects of tumour necrosis factor α upon the metabolism of the endocannabinoid anandamide in prostate cancer cells. |
| Q46427095 | Endocannabinoid metabolism in human glioblastomas and meningiomas compared to human non-tumour brain tissue |
| Q44827114 | Food intake is inhibited by oral oleoylethanolamide |
| Q52583978 | INSIGHT ON THE IMPACT OF ENDOCANNABINOID SYSTEM IN CANCER: A REVIEW. |
| Q46496591 | In vitro conjugation of ethanolamine with fatty acids by rat liver subcellular fractions |
| Q80065578 | Levels of N-acylethanolamines in human tumors: in search of reliable data |
| Q37686274 | Lipid analogues as potential drugs for the regulation of mitochondrial cell death |
| Q42156441 | Mammalian cells stably overexpressing N-acylphosphatidylethanolamine-hydrolysing phospholipase D exhibit significantly decreased levels of N-acylphosphatidylethanolamines |
| Q64259803 | Modulation of the Endocannabinoid System as a Potential Anticancer Strategy |
| Q57136128 | Oleoylethanolamide Supplementation Reduces Inflammation and Oxidative Stress in Obese People: A Clinical Trial |
| Q38964675 | Phorbol ester stimulates ethanolamine release from the metastatic basal prostate cancer cell line PC3 but not from prostate epithelial cell lines LNCaP and P4E6. |
| Q38955546 | Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas. |
| Q44569526 | Possible endocannabinoid control of colorectal cancer growth |
| Q47280730 | Secretion, isotopic labeling and deglycosylation of N-Acylethanolamine acid amidase for biophysical studies |
| Q35876026 | The endocannabinoid system and its therapeutic exploitation |
| Q37393042 | The endocannabinoid system and sex steroid hormone-dependent cancers. |
| Q38469671 | The evolving role of the endocannabinoid system in gynaecological cancer |
| Q64908003 | The orphan receptor GPR55 drives skin carcinogenesis and is upregulated in human squamous cell carcinomas. |
| Q37829751 | Update on the endocannabinoid system as an anticancer target |
Search more.